Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Thailand Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20072
20082
20091
20103
20131
20141
20151
20171
20183
20193
20201
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Merck Sharp & Dohme LLC3
Hoffmann-La Roche2
Imunon2
Bristol-Myers Squibb1
Eisai Limited1
Eli Lilly and Company1
Exelixis1
Light Sciences Oncology1
National Medical Research Council (NMRC), Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular24
Liver Neoplasms8
Neoplasms5
Carcinoma3
Adenocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Liver Diseases1
Neoplasms by Histologic Type1
Neoplasms by Site1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.